Why the Ramsay Health Care (ASX:RHC) share price tumbled lower today

The Ramsay Health Care Limited (ASX:RHC) share price tumbled lower on Thursday after announcing a major acquisition in the UK…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price was out of form on Thursday.

The private hospital operator's shares fell 3.5% to $62.30.

A worried doctor looks through a glass door.

Image source: Getty Images

Why did the Ramsay share price tumble?

The Ramsay share price came under pressure on Thursday after the market responded cautiously to the announcement of a new acquisition.

After the market close on Wednesday, Ramsay announced that it had made an offer of 1 billion pounds (A$1,822 million) to acquire 100% of Spire Healthcare. It is a London Stock Exchange-listed independent hospital group in the United Kingdom with a focus on the private patient market. It is also a leading provider of high-acuity care.

The Spire Board is unanimously recommending its shareholders vote in favour of the scheme. It also notes that major shareholders and directors, accounting for 30.4% of its shares, have made irrevocable undertakings to vote in its favour.

Management believes the acquisition will be transformational for Ramsay's UK business. It also expects to deliver benefits of at least 26 million pounds per annum from procurement savings, improved capacity utilisation, and cessation of UK listing costs. This is forecast to result in high single digit earnings per share accretion in FY 2024.

What was the response?

One leading broker that gave the acquisition a lukewarm response was Citi. In response to the news, the broker has held firm with its neutral rating and $67.00 price target.

Citi notes that the deal will increase its market share in the UK to 25% and is expected to generate decent synergies. However, the broker has some doubts over whether those synergies will be realised.

Commenting on the acquisition, Citi said: "Guiding to high single digit EPS accretion in FY24 Ramsay Healthcare has announced that it has bid 240p per share for Spire Healthcare Group, a 24% premium to the last close in an agreed deal. This values the equity of Spire at ~£1bn (A$1.822bn) and the EV post AASB16 at £2.064bn."

"The combined group would have ~25% of the UK private hospital market, with Spire currently having ~17% market share (~£1bn revenue in CY19) and RHC ~8% market share (~£540m revenue in FY19)."

"In CY19, Spire reported EBIT of £98m and RHC said its CY19 (pre-exceptional items) EBIT was £42m (but reported £26m in FY19). The company is forecasting "at least" £26m in synergies for the combined group, which seems reasonable on a combined revenue of ~£1.5b, although when Ramsay acquired Capio it made similar statements, and it is not obvious that those synergies have been realised (although in a different market)."

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why Brainchip, Fortescue, IGO, and Life360 shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

a woman sits next to her computer screen with her head in her hands with the screens slowing graphs on downward trajectories.
52-Week Lows

Can the beaten-down CSL share price ever reach $300 again?

CSL is near decade lows. Can it ever climb back?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Black Cat, Mirvac, Qantas, and Temple & Webster shares are falling today

These shares are having a tough session. But why?

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why Bank of Queensland, Cochlear, Northern Star, and Paladin Energy shares are falling today

These shares are having a difficult time on hump day. But why?

Read more »

An older man wearing glasses and a pink shirt sits back on his lounge with his hands behind his head and blowing air out of his cheeks.
Share Fallers

Why ANZ, Challenger, Hub24, and Lynas shares are dropping today

These shares are under pressure on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Monash IVF, NAB, Viva Energy, and Worley shares are falling today

These shares are starting the week in the red. But why?

Read more »